CN Patent

CN105085345B — 含硝基的l-薄荷醇类p2y12受体拮抗剂及其用途

Assigned to Tianjin Xiaoxin Pharmaceutical Technology Co Ltd · Expires 2016-09-14 · 10y expired

What this patent protects

本发明涉及与心血管疾病相关的药物领域。具体而言，本发明涉及一类含硝基的L‑薄荷醇结构的P2Y12受体拮抗剂、其制备方法以及在制备治疗心血管疾病尤其是血栓栓塞性疾病药物中的应用。

USPTO Abstract

本发明涉及与心血管疾病相关的药物领域。具体而言，本发明涉及一类含硝基的L‑薄荷醇结构的P2Y12受体拮抗剂、其制备方法以及在制备治疗心血管疾病尤其是血栓栓塞性疾病药物中的应用。

Drugs covered by this patent

cariprazine-hydrochloride (CARIPRAZINE HYDROCHLORIDE)

Patent Metadata

Patent number: CN105085345B
Jurisdiction: CN
Classification: —
Expires: 2016-09-14
Drug substance claim: No
Drug product claim: No
Assignee: Tianjin Xiaoxin Pharmaceutical Technology Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.